VISCHER advised e-hoi AG on the deal. Cruise Center AG, a Swiss company that has been selling cruises for over twenty years, was acquired by the...
e-hoi AG’s Acquisition of Cruise Center AG
ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round
Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
Engimmune Therapeutics’ CHF 15.5 Million Seed Financing Round
Walder Wyss advised Engimmune Therapeutics on the deal. Vischer advised the investors Pureos Bio-ventures and Novo Holdings. Engimmune Therapeutics completed a CHF 15.5m seed financing round co-led...
Alloy Therapeutics’ Acquisition of deepCDR Biologics
Walder Wyss acted as Swiss legal counsel for Alloy Therapeutics Inc on the deal. Vischer advised deepCDR Biologics AG. Alloy Therapeutics, a biotechnology ecosystem company, acquired...
Vifor Pharma’s CHF 20 Million Acquisition of Inositec
Kellerhals Carrard advised Vifor Pharma on the transaction. Vischer advised Inositec on the deal. Vifor Pharma acquired the Swiss firm Inositec AG, a clinical stage biopharmaceutical company...
GlycoEra’s CHF 45 Million Series A Financing Round
Vischer advised GlycoEra AG on the deal. Walder Wyss advised 5AM Ventures, Roche Venture Fund and Sofinnova Partners as lead investors. GlycoEra AG has closed CHF...
Afinum Management GmbH’s CHF 105 Million Acquisition of GS Swiss PCB
VISCHER advised the buyer on this transaction. Bär & Karrer acts as legal advisor to exceet Group in this transaction. A fund advised by AFINUM Management...
Nautilus’ Acquisition of VAY AG
Walder Wyss has advised the selling founders on the deal. Vischer advised the buyer. Nautilus, Inc. (NYSE: NLS), an innovation leader in home fitness, has acquired...
Anjarium Biosciences’ CHF 55.5 Million Series A Financing Round
VISCHER advised Anjarium Biosciences on the deal. Baker McKenzie advises a consortium of life science funds, including Abingworth and Gimv, alongside Omega Funds, Pfizer Ventures and...
EGO Movement’s Strategic Partnership With TVS Motor
VISCHER advised EGO Movement on the deal. MLL advised TVS Motor Company on this transaction. The fast-growing Swiss e-mobility company EGO Movement (the GO AG) has...
Combioxin’s Licensing Agreement With Eagle Pharmaceuticals
VISCHER advised Combioxin SA on the deal. Combioxin SA, a clinical-stage biotechnology company based in Epalinges, Switzerland, entered into a worldwide licensing agreement with Eagle Pharmaceuticals,...
Novartis’ Collaboration Agreement With Cellerys
VISCHER AG has advised Novartis AG in this transaction. Novartis has signed a collaboration agreement and an option to acquire Cellerys. The Zurich-based startup is researching...